Chronic L-DOPA administration induces dy
β
R. K. B. Pearce; M. Jackson; L. Smith; Prof. P. Jenner; C. D. Marsden
π
Article
π
1995
π
John Wiley and Sons
π
English
β 934 KB
## Abstract Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with LβDOPA and also occur in several nonhuman primate species after 1βmethylβ4βphenylβ1,2,3,6βtetrahydropyridine (MPTP) and LβDOPA treatment. The common marmoset (__Callithrix jacchus__) shows pa